• PIH54 UNMET NEEDS IN THE DIAGNOSIS AND MANAGEMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER IN THE REAL WORLD

    May 1, 2019, 00:00

  • PNS233 A NEWLY DEVELOPED POWER PROCEDURE FOR SAMPLE SIZE PLANNING IN COA VALIDATION STUDIES

    May 1, 2019, 00:00

  • PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PH4 ASSOCIATION BETWEEN POLYPHARMACY AND HEALTH-RELATED QUALITY OF LIFE AMONG CANCER SURVIVORS IN THE UNITED STATES

    May 1, 2019, 00:00

  • Early Assessment of Proof-of-Problem to Guide Health Innovation

    May 1, 2019, 00:00

  • PGI9 SURGERY-RELATED COSTS AVERTED BY THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE CALCULATED THROUGH A MATHEMATICAL MODEL

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PMH19 COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS192 MULTI-COMPARATOR INCREMENTAL COST EFFECTIVENESS: A NOVEL APPROACH TO ASSESS THE COST-EFFECTIVENESS OF HEALTHCARE INTERVENTIONS

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2019, 00:00

  • PCN255 AN ENHANCED APPROACH FOR ESTIMATING MEAN SURVIVAL TIME BASED ON FINITE MIXTURE MODELS: REDUCING UNCERTAINTY IN COST EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PNS153 THE PROVISION OF GATE-KEEPING PRACTICE TO MITIGATE THE ADVERSE EFFECTS OF LONG-TERM UNEMPLOYMENT DURING ECONOMIC CRISIS

    May 1, 2019, 00:00

  • NO Specific Disease - Epidemiology Public Health

    May 1, 2019, 00:00

  • PMD7 FEMUR FRACTURES BY ANATOMY- RATES AND COSTS IN A HOSPITAL BILLING DATABASE

    May 1, 2019, 00:00

  • PGI17 COMORBID MENTAL HEALTH DISORDERS AND PATIENT-REPORTED PAIN SCORES IN IRRITABLE BOWEL SYNDROME PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • Drugs Information Systems

    May 1, 2019, 00:00

  • Infectious Diseases - Clinical Outcomes

    May 1, 2019, 00:00

  • PCN279 IMPACT OF DEPRESSION AND ANXIETY ON ADHERENCE TO ADJUVANT ENDOCRINE TREATMENTS IN ELDERLY BREAST CANCER SURVIVORS

    May 1, 2019, 00:00

  • PCV89 ANALYSIS OF THE LIST OF MEDICINES FOR TREATMENT OF HYPERTENSION IN PREGNANCY IN UKRAINE

    May 1, 2019, 00:00

  • PNS169 SIMILARITIES DIFFERENCES IN GLOBAL VALUE DOSSIER (GVD) AND ACADEMY OF MANAGED CARE PHARMACY (AMCP) DOSSIER DEVELOPMENT

    May 1, 2019, 00:00

  • PDG81 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE) UTILIZATION AND ADHERENCE IN WOMEN WITH A HIGH-RISK PREGNANCY

    May 1, 2019, 00:00

  • PNS182 REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS

    May 1, 2019, 00:00

  • PNS157 IDENTIFICATION AND COST OF DIAGNOSTIC TESTS FOR INFECTION IN DIABETIC FOOT ULCERS, PRESSURE ULCERS, AND VENOUS LEG ULCERS

    May 1, 2019, 00:00

  • PDB63 THE IMPACT OF HEART FAILURE ON DIABETES-RELATED HEALTHCARE UTILIZATION AND COSTS IN ADULT PATIENTS WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PMS25 CHARACTERISTICS AND MONETARY COMPENSATION OF CAREGIVERS FOR PATIENTS WITH RHEUMATIC CONDITIONS

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PNS144 EFFECT OF FACILITY OWNERSHIP STRUCTURE ON TIME SPEND BY PHYSICIANS WITH PATIENTS

    May 1, 2019, 00:00

  • PDB111 PREDICTORS OF MEDICATION ADHERENCE AMONG ELDERLY STATE PHARMACEUTICAL ASSISTANCE PROGRAM BENEFICIARIES

    May 1, 2019, 00:00

  • PMU95 BCBSLA APPROACH USING NATURAL LANGUAGE PROCESSING (NLP) AND MACHINE LEARNING TO PREDICT THE RISK OF HOSPITALIZATIONS

    May 1, 2019, 00:00

  • PMS32 VOLUME AND CHARACTERISTICS OF SPINAL DEFORMITY SURGICAL PATIENTS

    May 1, 2019, 00:00

  • PNS149 THE MEDICAL AND SOCIAL MODELS OF DISABILITY.

    May 1, 2019, 00:00

  • PNS114 BUNDLED PAYMENTS FOR CARE IMPROVEMENT ADVANCED (BPCI-A): AN ANALYSIS OF PUBLIC COMMUNICATIONS DURING THE APPLICATION PERIOD

    May 1, 2019, 00:00

  • PIN80 PSYCHOMETRICS OF AN INSTRUMENT TO MEASURE PHARMACIST-PROVIDER COLLABORATION FOR PHARMACISTS IN HIV PATIENT CARE IN AMBULATORY SETTINGS

    May 1, 2019, 00:00

  • PIN72 NONOCCUPATIONAL HIV POST-EXPOSURE PROPHYLAXIS IN NIGERIA: AN OVERVIEW OF RESEARCH STUDIES AND IMPLICATIONS FOR POLICY AND PRACTICE

    May 1, 2019, 00:00

  • PIT19 MORTALITY AND ACUTE BURDEN OF BURN INJURY IN A MEDICAL CENTER IN TAIWAN

    May 1, 2019, 00:00

  • PIN43 THE ECONOMIC BURDEN OF ANTIMICROBIAL RESISTANCE: RESULTS FROM A TARGETED LITERATURE REVIEW

    May 1, 2019, 00:00

  • PMU82 EFFECT OF CARBAPENEM RESISTANCE ON TOTAL HOSPITALIZATION COSTS AMONG INPATIENTS WITH PSEUDOMONAS AERUGINOSA: A MULTICENTER STUDY IN CHINA

    May 1, 2019, 00:00

  • PDG60 DID CITIZEN PETITIONS PROLONG THE NUMBER OF APPROVAL DAYS OF GENERIC DRUGS?

    May 1, 2019, 00:00

  • PCV65 REAL-WORLD CHARACTERISTICS AND READMISSIONS AMONG PATIENTS UNDERGOING ABLATION FOR VENTRICULAR TACHYCARDIA: A RETROSPECTIVE DATABASE ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN278 REAL WORLD TREATMENT PATTERNS FOR FIRST LINE (1L) RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PATIENTS

    May 1, 2019, 00:00

  • PIH67 WHAT ELSE CAN COW MILK PROTEIN BE RESPONSIBLE FOR? – BEHAVIOURAL PROBLEMS IN CHILDREN WITH COW MILK PROTEIN ALLERGY

    May 1, 2019, 00:00

  • PCN244 UNBIASED TREATMENT EFFICACY DETECTION METHODS WHEN USING PATIENT REPORTED OUTCOMES IN SURVIVAL-DEPENDENT DROP-OUT

    May 1, 2019, 00:00

  • PND78 PATIENT REPORTED OUTCOMES TOOLS AND SHARED DECISION-MAKING IN PEDIATRIC EPILEPSY POPULATION AND THEIR CAREGIVERS: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PDB22 ANTIHYPERGLYCEMIC TREATMENT REGIMENS BEFORE AND AFTER A SKILLED NURSING FACILITY STAY AMONG PATIENTS WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PDB49 COST OFFSET MODEL USING MONTE-CARLO SIMULATION SHOWED REDUCED EMERGENCY MEDICAL PER-EVENT COSTS FOR NASAL GLUCAGON VERSUS INJECTABLE GLUCAGON

    May 1, 2019, 00:00

  • Infectious Diseases - Methodological Statistical Research

    May 1, 2019, 00:00

  • PND73 DIFFERENTIATION OF EPISODIC MIGRAINE AND CHRONIC MIGRAINE USING A MACHINE LEARNING TECHNIQUE

    May 1, 2019, 00:00

  • Neurological Disorders - Medical Technologies

    May 1, 2019, 00:00

  • PMS45 OPIOID USAGE AND PATIENT-REPORTED PAIN SCORES IN OSTEOARTHRITIS PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • Infectious Diseases - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PMU60 DEVELOPMENT OF A MEASURE OF PRESCRIBER SATISFACTION WITH ACADEMIC DETAILING

    May 1, 2019, 00:00

  • PDG25 COST-EFFECTIVENESS OF ONCE WEEKLY DULAGLUTIDE 1.5 MG VERSUS ONCE DAILY LIRAGLUTIDE 1.8 MG FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA

    May 1, 2019, 00:00

  • PMU89 APPLIED COMPARISON OF CARDINALITY MATCHING VERSUS PROPENSITY SCORE MATCHING FOR CAUSAL INFERENCE IN OBSERVATIONAL MEDICAL DEVICE RESEARCH: MINIMALLY-INVASIVE VERSUS OPEN THORACIC SEGMENTECTOMY

    May 1, 2019, 00:00

  • PMU108 EFFECT OF TREATMENT PREFERENCE IN RANDOMIZED CONTROLLED TRIALS: SYSTEMATIC REVIEW OF LITERATURE AND META-ANALYSIS

    May 1, 2019, 00:00

  • PMD21 COST BENEFIT ANALYSIS FOR CENTRIFUGAL VERSUS MEMBRANE-BASED THERAPEUTIC PLASMA EXCHANGE

    May 1, 2019, 00:00

  • PNS60 CULTURAL AND SOCIAL FACTORS AFFECTING CIGARETTE SMOKING HABITS AMONG YOUNG EDUCATED PEOPLE IN KURDISTAN REGION / IRAQ

    May 1, 2019, 00:00

  • PND88 QUANTITATIVE RESEARCH IN PSYCHIATRY: CLINICAL UTILITY OF EXTENDED- AND IMMEDIATE-RELEASE FORMULATIONS OF AMANTADINE FOR DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PIN70 ASSOCIATION BETWEEN INFLUENZA VACCINE EFFECTIVENESS AND HEALTHCARE UTILIZATIONS AMONG US ELDERLY POPULATION

    May 1, 2019, 00:00

  • PIN93 PREDICTION MODEL OF TREATMENT FAILURE AMONG CHRONIC HEPATITIS C PATIENTS AT FOUR UNITED STATES INSTITUTIONS

    May 1, 2019, 00:00

  • PMU27 1-YEAR POSTTRANSPLANT DIRECT NON-MEDICAL AND INDIRECT COSTS FOR RECIPIENTS AND CAREGIVERS IN THAILAND: A SURVEY FROM 5 TRANSPLANT CENTERS

    May 1, 2019, 00:00

  • PIN53 PREDICTORS OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE SERIES ADHERENCE AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS IN THE UNITED STATES DURING 2006-2016

    May 1, 2019, 00:00

  • PND82 IMPACT OF EPTINEZUMAB ON THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH EPISODIC OR CHRONIC MIGRAINE: SF-36 ANALYSIS BY MONTHS 1 AND 3 ACROSS THE SPECTRUM OF MIGRAINE

    May 1, 2019, 00:00

  • PMD12 HEALTH ECONOMIC IMPACT OF THE TECHNOLOGY “OSTEOSYNTHESIS” ON FRACTURE CARE: AN ECONOMIC ANALYSIS FOR 17 HIGH INCOME COUNTRIES OVER THE COURSE OF 60 YEARS

    May 1, 2019, 00:00

  • PNS12 WHY ADVANCING DATA VISUALIZATION DOGMA IS OUR BEST TOOL IN DISAMBIGUATING RESEARCH FINDINGS

    May 1, 2019, 00:00

  • PNS227 STRESS AND ITS ASSOCIATION WITH ADVANCED PHARMACY PRACTICE EXPERIENCES AMONG PHARMACY STUDENTS

    May 1, 2019, 00:00

  • PIH5 DEVELOPMENT OF THE SIDE EFFECTS OF PEANUT ORAL IMMUNOTHERAPY DIARY (SEPOD)

    May 1, 2019, 00:00

  • PMU41 ASSOCIATION BETWEEN POLYPHARMACY AND HEALTH-RELATED QUALITY OF LIFE AMONG US ADULTS WITH CARDIOMETABOLIC RISK FACTORS: A POPULATION-LEVEL ANALYSIS

    May 1, 2019, 00:00

  • PND76 ROLE OF MESSAGE FRAMING AND INVOLVEMENT ON INTENTION TO ENGAGE IN PREVENTIVE BEHAVIORS FOR COGNITIVE HEALTH MAINTENANCE

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PIN33 COST-EFFECTIVENESS ANALYSIS OF EFINACONAZOLE FOR THE TREATMENT OF MILD TO MODERATE TOENAIL ONYCHOMYCOSIS IN CANADA

    May 1, 2019, 00:00

  • PMS50 OPIOID USE, HEALTHCARE EXPENDITURES, AND PAIN SEVERITY IN OSTEOARTHRITIS PATIENTS USING PATIENT REPORTED PAIN SCORES TO ASSESS PAIN SEVERITY

    May 1, 2019, 00:00

  • PDB70 PREVALENCE OF PERIPHERAL NEUROPATHY AND ASSOCIATED PAIN IN PATIENTS WITH DIABETES MELLITUS

    May 1, 2019, 00:00

  • R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment

    May 1, 2019, 00:00

  • Association Between Patient Experience With Patient-Reported Outcome Measurements and Overall Satisfaction With Care in Neurology

    May 1, 2019, 00:00

  • PDB24 COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PMD36 REDUCTION IN PEDICLE SCREW PLACEMENT TIME WITH A NOVEL GUIDEWIRELESS PEDICLE SCREW SYSTEM FOR MINIMALLY INVASIVE SPINE SURGERY: INITIAL FINDINGS

    May 1, 2019, 00:00

  • PMU53 ASSESSMENT OF THE ROUTES OF PATIENTS IN HUNGARIAN ONE-DAY SURGERY

    May 1, 2019, 00:00

  • PCV87 CHARACTERISTICS OF ATRIAL FIBRILLATION PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AND HAVING UNDERGONE CARDIOVERSION

    May 1, 2019, 00:00

  • PNS237 TIME TRADE-OFF TARIFFS BASED ON SF-12 QUESTIONNAIRE

    May 1, 2019, 00:00

  • PND80 RAPID MIGRAINE RESPONSE BY MONTH 1 AND CLINICALLY MEANINGFUL IMPROVEMENTS IN HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MIGRAINE IN PHASE 3 TRIALS OF EPTINEZUMAB

    May 1, 2019, 00:00

  • PNS225 A UNIFIED ANALYSIS AND MODELING FRAMEWORK FOR THE DESIGN OF OUTCOMES-BASED RISK-SHARING AGREEMENTS

    May 1, 2019, 00:00

  • PMU13 WHY IS QUALITATIVE EVIDENCE SYNTHESIS OVERLOOKED AND UNDERVALUED?

    May 1, 2019, 00:00

  • PMD14 COST-EFFECTIVENESS OF SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY (SNPWT) VS TRADITIONAL NPWT FOR THE TREATMENT OF LOWER EXTREMITY ULCERS

    May 1, 2019, 00:00

  • Adherence, Persistence and Compliance Studies

    May 1, 2019, 00:00

  • Infectious Diseases - Economic Evaluation

    May 1, 2019, 00:00

  • Drugs Generics - Clinical Outcomes

    May 1, 2019, 00:00

  • Neurological Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • PCV14 AN APPRAISAL OF REAL-WORLD EVIDENCE (RWE) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS)

    May 1, 2019, 00:00

  • PNS170 NICE END OF LIFE - SURVIVAL CRITERION: STRICT IMPLEMENTATION OR PRAGMATIC FLEXIBILITY?

    May 1, 2019, 00:00

  • PIH73 DEVELOPMENT OF ILLUSTRATIONS TO FACILITATE CONCEPT ELICITATION INTERVIEWS WITH PEDIATRIC PARTICIPANTS

    May 1, 2019, 00:00

  • PNS138 EVALUATION OF COLLABORATIONS AND PARTNERSHIPS ACROSS HEALTHCARE INDUSTRY SEGMENTS TO DRIVE TRIPLE AIM GOALS

    May 1, 2019, 00:00

  • PCV64 PRIOR USE OF MEDICATION FOR PRIMARY PREVENTION IN PATIENTS WITH CORONARY SYNDROME

    May 1, 2019, 00:00

  • PCN242 APPROACHES TO PRAGMATIC METHODOLOGY IN ONCOLOGY RETROSPECTIVE STUDIES

    May 1, 2019, 00:00

  • PMU11 A COMPARISON BETWEEN ICER AND NICE COST-EFFECTIVENESS MODELS

    May 1, 2019, 00:00

  • PNS194 COMPARISON OF SIMULATED CLINICIAN RANKINGS WITH SEMI-AUTOMATED AND AUTOMATED ALGORITHMS FOR VARIABLE SELECTION WHEN CONDUCTING ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISONS

    May 1, 2019, 00:00

  • PCV11 COMPARATIVE EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN AMONG PATIENTS ADMITTED TO INTENSIVE CARE: ANALYSIS OF ELECTRONIC HEALTH RECORD DATA

    May 1, 2019, 00:00

  • PND46 PREDICTORS OF DELIRIUM AMONG CARDIOVASCULAR SURGICAL INTENSIVE CARE UNIT PATIENTS AT DEBAKEY HEART CENTER

    May 1, 2019, 00:00

  • PNS77 ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICES: REGULATORY AND REIMBURSEMENT LANDSCAPE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS11 PATIENT-CENTERED METHODS: CONSIDERATIONS FOR QUALITATIVE RESEARCH TO SUPPORT CONTENT VALIDITY WHEN DEVELOPING CLINICAL OUTCOME ASSESSMENT (COA) MEASURES APPROPRIATE FOR ADOLESCENT PATIENTS (AGED 12-17 YEARS OLD)

    May 1, 2019, 00:00

  • PIN4 VIROLOGIC OUTCOMES AMONG TREATMENT NAIVE HIV+ PATIENTS INITIATING COMMON FIRST ANTIRETROVIRAL THERAPY CORE AGENTS IN THE OPERA OBSERVATIONAL DATABASE

    May 1, 2019, 00:00

  • PNS219 A NOVEL METHOD FOR ASSESSING FEASIBILITY OF GENERATING REAL-WORLD DATA BASED CONTROL GROUPS

    May 1, 2019, 00:00

  • Medical Devices - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • Cancer - Patient-Centered Research

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PCV111 SAFETY PROFILE OF AMIODARONE AND DRONEDARONE: A PHARMACOEPIDEMIOLOGIC ANALYSIS USING FDA ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATABASE.

    May 1, 2019, 00:00

  • Mental Health - Health Policy Regulatory

    May 1, 2019, 00:00

  • PDG38 PREVIOUSLY UNKNOWN RISK OF PERIPHERAL NEUROPATHY WITH CEFOXITIN AND AMIKACIN

    May 1, 2019, 00:00

  • PND7 A LONGITUDINAL EXAMINATION OF PROGRESSION-RELATED EVENTS AMONG MEDICARE BENEFICIARIES WITH AND WITHOUT PARKINSON'S DISEASE

    May 1, 2019, 00:00

  • PIN74 IMPACT OF HEALTHCARE UTILIZATION ON MENINGOCOCCAL ADOLESCENT VACCINATION IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PDB2 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOTHERAPIES FOR THE TREATMENT OF OBESITY AMONG ADULTS: A SYSTEMATLIC LITERATURE AND NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PIN51 HEALTHCARE RESOURCE UTILIZATION OF STAGE 3 STAGE 4 PRESSURE ULCER (PU) AND DIABETIC FOOT ULCER (DFU) PATIENTS TREATED EARLY WITH CLOSTRIDIAL COLLAGENASE OINTMENT (CCO) - A PAYER’S PERSPECTIVE

    May 1, 2019, 00:00

  • PMU88 USING MACHINE LEARNING FOR PHENOTYPIC PREDICTION TO EXPLORE COMPLEX CODING PATTERNS IN REAL-WORLD HEALTHCARE DATABASES: AN APPLICATION TO SURGICAL CONVERSION

    May 1, 2019, 00:00

  • PNS165 TRENDS IN THE UPTAKE AND IMPACT OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) VALUE ASSESSMENT FRAMEWORK (VAF) IN COVERAGE DECISIONS

    May 1, 2019, 00:00

  • PPM5 TIMING AND THE COST-EFFECTIVENESS OF POPULATION-WIDE GENOMIC SCREENING FOR BREAST AND OVARIAN CANCER

    May 1, 2019, 00:00

  • PIN25 IMPACT OF ANTIBIOTIC RESISTANCE ON TREATMENT OF PNEUMOCOCCAL DISEASE IN ETHIOPIA: AN AGENT-BASED MODELING SIMULATION

    May 1, 2019, 00:00

  • PNS187 US NATIONAL TRENDS OF MOBILE HEALTH APPS USE IN 2014 AND 2018

    May 1, 2019, 00:00

  • Drugs Generics - Economic Evaluation

    May 1, 2019, 00:00

  • PMU57 A REMEDY FOR DESPAIR? SHORT-TERM CHANGES IN ECONOMIC CONDITIONS AND OPIOID PRESCRIBING IN WASHINTON STATE

    May 1, 2019, 00:00

  • PMD41 ECONOMIC IMPACT OF NOVEL DIGITAL THERAPEUTICS IN DIABETES, DYSLIPIDEMIA, AND HYPERTENSION

    May 1, 2019, 00:00

  • PMU101 MOST BOTHERSOME SYMPTOM MEASUREMENT STRATEGIES: CONSIDERATIONS FOR REGULATED CLINICAL TRIALS

    May 1, 2019, 00:00

  • PMH41 IMPACT OF GEOGRAPHIC ACCESS TO PROVIDERS ON TREATMENT ENGAGEMENT AND COMPLETION IN PEDIATRIC DEPRESSION POPULATION IN SOUTHEAST TEXAS

    May 1, 2019, 00:00

  • PCV37 REIMBURSEMENT OF AMBULATORY BLOOD PRESSURE MONITORING IN THE COMMERCIAL INSURANCE MARKETPLACE

    May 1, 2019, 00:00

  • PNS3 RETHINKING THE IMPACT OF FORMULARY CHANGES ON PATIENT HEALTH OUTCOMES

    May 1, 2019, 00:00

  • PIN59 BURDEN OF DISEASE OF HEALTHCARE-ASSOCIATED INFECTIONS IN ARGENTINA

    May 1, 2019, 00:00

  • PIN57 PREVALENCE OF MEDICARE BENEFICIARIES WITH A RECENT DIAGNOSIS OF CHRONIC HEPATITIS C IN 2016

    May 1, 2019, 00:00

  • PNS199 PREDICTING FALLS IN ELDERLY PATIENTS USING CLAIMS DATA: A TIME-AWARE DEEP LEARNING APPROACH

    May 1, 2019, 00:00

  • PND10 SYSTEMATIC LITERATURE REVIEW OF OUTCOMES ASSOCIATED WITH SINGLE AND DUAL STENT-ASSISTED COIL EMBOLIZATION IN WIDE-NECKED BIFURCATION ANEURYSMS

    May 1, 2019, 00:00

  • PDB117 A NEW MODEL OF INTEGRATED CARE FOR COMPLEX TYPE 2 DIABETES IN UNDERSERVED POPULATIONS: A STUDY PROTOCOL FOR A COST-EFFECTIEVENESS ANALYSIS

    May 1, 2019, 00:00

  • PIT21 EXPLORING COST OF AND TREATMENT PATTERNS WITH AUTOGRAFT DURING HOSPITALIZATIONS FOR THERMAL BURN PATIENTS IN A COMMERCIALLY INSURED POPULATION

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • PDG2 EFFICACY OF PIOGLITAZONE IN IMPROVING LIVER HISTOLOGY SCORES OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC-REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PCV103 A CLOSER LOOK AT MEDICATION ADHERENCE AND THE ROLE OF IMPROVED BEHAVIORS AND DEPRESSION

    May 1, 2019, 00:00

  • PMD25 FACTORS INFLUENCING PHYSICIAN'S PRESCRIPTION AND REIMBURSEMENT OF MEDICAL DEVICES USED IN LARYNGECTOMY REHABILITATION IN EUROPE

    May 1, 2019, 00:00

  • PCN257 USE OF AUC IN ONCOLOGY SURVIVAL CURVE TO ASSESS COST IN MEA NEGOATION

    May 1, 2019, 00:00

  • PNS69 FACTORS ASSOCIATED WITH INITIATION OF E-CIGARETTE AMONG MIDDLE SCHOOL VS. HIGH SCHOOL CHILDREN

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PND52 PATTERNS OF UTILIZATION OF DRUGS FOR MIGRAINE IN A COLOMBIAN POPULATION

    May 1, 2019, 00:00

  • PNS222 IMPUTATION TECHNIQUES FOR MISSING COVARIATES WHEN MODELING DISEASE PROGRESSION

    May 1, 2019, 00:00

  • PCV106 ADHERENCE TO SELF-CARE RECOMMENDATIONS AND ASSOCIATED FACTORS AMONG ADULT HEART FAILURE PATIENTS AT GONDAR UNIVERSITY REFERRAL HOSPITAL, NORTHWEST ETHIOPIA

    May 1, 2019, 00:00

  • PMD39 MEASURING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SICKLE CELL DISEASE UNDERGOING AUTOMATED RED BLOOD CELL EXCHANGE

    May 1, 2019, 00:00

  • PDB34 TRANSLATING THE REDUCTION OF GLYCATED HEMOGLOBIN INTO ECONOMIC AND CLINICAL CONSEQUENCES OF PATIENTS WITH HIGH CARDIOVASCULAR RISK. AN INCIDENCE MODEL FOR CHILEAN POPULATION WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PDB71 VALIDITY AND RELIABILITY OF HINT-8 IN PATIENTS WITH DIABETES MELLITUS

    May 1, 2019, 00:00

  • PMH44 ASSESSMENT OF ADHERENCE TO ADHD TREATMENT GUIDELINES AND IMPACT ON HEALTH RESOURCE UTILIZATION

    May 1, 2019, 00:00

  • PIN5 REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

    May 1, 2019, 00:00

  • PNS132 VALUE-BASED CONTRACTS - WHEN AND HOW CAN THEY ACTUALLY WORK?

    May 1, 2019, 00:00

  • PDB36 ESTIMATING NATIONAL-LEVEL COST SAVINGS ASSOCIATED WITH REDUCTIONS IN BODY MASS INDEX IN THE US OBESE POPULATION

    May 1, 2019, 00:00

  • PND20 COST-UTILITY OF CANNABIDIOL IN ADDITION TO BACKGROUND THERAPY VERSUS BACKGROUND THERAPY ALONE IN LENNOX-GASTAUT SYNDROME

    May 1, 2019, 00:00

  • PND2 TRANSITIONS ACROSS COGNITIVE STATES WITH OR WITHOUT THE USE OF FDA-APPROVED MEDICATIONS FOR ALZHEIMER'S DISEASE

    May 1, 2019, 00:00

  • PDG74 DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS (2014-2017)

    May 1, 2019, 00:00

  • PMU66 EXAMINING THE RELATIONSHIP BETWEEN PATIENT SATISFACTION AND ANTIBIOTIC PRESCRIBING FOR ACUTE ADULT BRONCHITIS IN AN AMBULATORY SETTING

    May 1, 2019, 00:00

  • PCV55 TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF CARE AMONG PATIENTS WITH NEWLY DIAGNOSED SYSTOLIC AND DIASTOLIC HEART FAILURE IN A US REAL-WORLD SETTING

    May 1, 2019, 00:00

  • PCV107 PREFERENCE AND WILLINGNESS-TO-PAY FOR NOVEL ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – PRELIMINARY RESULTS FROM A TWO-CENTRE SURVEY IN CHINA

    May 1, 2019, 00:00

  • PNS197 TWO APPROACHES TO EVALUATE MISSING CLINICAL OUTCOME ASSESSMENT RESPONSES: A SIMULATION STUDY

    May 1, 2019, 00:00

  • PIN37 COST-EFFECTIVENESS ANALYSIS OF FIDAXOMICIN FOR CLOSTRIDIUM DIFFICILE INFECTION IN JAPAN

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PGI15 ONE-YEAR RESOURCE USE FOR MEDICATION-REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE PATIENTS TREATED WITH LAPAROSCOPIC NISSEN FUNDOPLICATION OR LINX REFLUX MANAGEMENT SYSTEM: A SURVEY OF 99 U.S. CLINICIANS

    May 1, 2019, 00:00

  • PDB17 INDIRECT TREATMENT COMPARISON OF SGLT2 INHIBITOR MONOTHERAPY IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES ON DIET/EXERCISE OR METFORMIN

    May 1, 2019, 00:00

  • PIN89 COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL CONJUGATE VACCINES IN CHILDREN IN A DINAMIC COHORT IN COLOMBIA, 2018-2027

    May 1, 2019, 00:00

  • PMU25 RISK FACTORS FOR CVD ARE ASSOCIATED WITH INCREASED HEALTH CARE EXPENDITURES FOR PERSONS WITH SERIOUS MENTAL ILLNESS

    May 1, 2019, 00:00

  • PGI6 ECONOMIC BURDEN OF PROGRESSION TO CIRRHOSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES

    May 1, 2019, 00:00

  • PIN23 COST-EFFECTIVENESS EVALUATION OF ARTIFICIAL INTELLIGENCE MONITORING OF ACTIVE TUBERCULOSIS TREATMENT IN LOS ANGELES COUNTY, CALIFORNIA: A PILOT STUDY

    May 1, 2019, 00:00

  • PDG8 EFFICACY OF PHARMACOLOGICAL MONOTHERAPIES FOR TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PCV36 HEALTHCARE EXPENDITURES IN PATIENTS RECEIVING PHARMACOTHERAPY WITH APIXABAN OR WARFARIN FOR VENOUS THROMBOEMBOLISM (VTE): A COMPARATIVE STUDY

    May 1, 2019, 00:00

  • PCV42 MYOCARDIAL INFARCTION: ECONOMIC, HEALTH, AND SOCIAL IMPACTS ON INFORMAL CAREGIVERS

    May 1, 2019, 00:00

  • PMH36 NON-SELECTIVE ANTIMUSCARINIC MEDICATION USE AMONG ELDERLY DEMENTIA PATIENTS WITH OVERACTIVE BLADDER

    May 1, 2019, 00:00

  • Mental Health - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS47 ASSESSMENT OF RESIDENTS' WILLINGNESS TO PAY FOR PHARMACEUTICAL CARE PROVIDED BY LICENSED PHARMACIST IN COMMUNITY PHARMACY IN SICHUAN PROVINCE OF CHINA

    May 1, 2019, 00:00

  • PDG57 THE IMPACT OF GENERIC MARKET EXCLUSIVITY BY THE PATENT-REGISTRATION LINKAGE SYSTEM IN KOREA

    May 1, 2019, 00:00

  • PMU61 VARIABLE BIOSIMILAR COVERAGE ACROSS US COMMERCIAL PLANS

    May 1, 2019, 00:00

  • PNS196 USE OF MACHINE LEARNING IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR): OPTIMIZING PREDICTIVE MODELS

    May 1, 2019, 00:00

  • PNS112 MANAGEMENT OF SPECIALTY DRUGS, SPECIALTY PHARMACIES, AND BIOSIMILARS IN THE UNITED STATES

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Health Technology Assessment

    May 1, 2019, 00:00

  • Medical Devices - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS79 IMPACT OF INTERNATIONAL REFERENCE PRICING ON FIVE PRODUCTS IN THE USA

    May 1, 2019, 00:00

  • PNS73 SEVERE ATOPIC DERMATITIS IN SPAIN: POPULATION-BASED EPIDEMIOLOGICAL STUDY

    May 1, 2019, 00:00

  • PIH16 ECONOMIC AND CLINICAL OUTCOMES AMONG WOMEN WITH ABNORMAL UTERINE BLEEDING TREATED WITH INPATIENT OR OUTPATIENT HYSTERECTOMY VERSUS ENDOMETRIAL ABLATION

    May 1, 2019, 00:00

  • PDB14 REAL WORLD INFLUENCING FACTORS OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND GLYCEMIC PREDICT MODELS BASED ON MAIN INFLUENCING FACTORS

    May 1, 2019, 00:00

  • PIH27 THE CASE FOR THE INCLUSION OF HUMAN MILK INTO GEORGIA STATE'S MEDICAID REIMBURSEMENT STRUCTURE: A BUDGET IMPACT ANALYSIS

    May 1, 2019, 00:00

  • PIN21 COST-EFFECTIVENESS ANALYSIS OF TAFENOQUINE WITH A RAPID DIAGNOSTIC TEST FOR G6PD DEFICIENCY IN PATIENTS WITH PLASMODIUM VIVAX INFECTIONS IN BRAZIL

    May 1, 2019, 00:00

  • PMS6 ANALYSIS OF A JUMP-LANDING TASK BETWEEN INJURED AND UNINJURED ADOLESCENT BASKETBALL PLAYERS

    May 1, 2019, 00:00

  • PMD4 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE IN HIP AND KNEE REPLACEMENT 90-DAY EPISODE CLAIMS

    May 1, 2019, 00:00

  • PMU104 EXPLAINING DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE (HRQOL) BETWEEN PERSISTENT AND NON-OPIOID USERS WITH CHRONIC NON-CANCER PAIN CONDITIONS (CNCP): A POST-REGRESSION DECOMPOSITION ANALYSIS.

    May 1, 2019, 00:00

  • PDG7 WEIGHT LOSS AND SAFETY OF FOUR APPETITE SUPPRESSANTS DRUG: A META-ANALYSIS

    May 1, 2019, 00:00

  • PNS195 MODELLING HETEROGENEOUS PUBLIC PREFERENCES IN DISCRETE CHOICE EXPERIMENTS: AN APPLICATION TO PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES FOR CHROMOSOMAL ABNORMALITIES

    May 1, 2019, 00:00

  • PMS41 CHANGES OVER TIME IN TREATMENT AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN JAPAN: EVIDENCE FROM JMDC INC. DATABASE

    May 1, 2019, 00:00

  • Combining Health and Outcomes Beyond Health in Complex Evaluations of Complex Interventions: Suggestions for Economic Evaluation

    May 1, 2019, 00:00

  • PIH36 ECONOMIC BURDEN OF UNINTENDED PREGNANCY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS129 PRIVATE PAYER PERSPECTIVES ON THE BENEFITS OF FEDERAL ANTI-KICKBACK STATUTE MODERNIZATION TO PROMOTE VALUE-BASED ARRANGEMENTS FOR MEDICINES

    May 1, 2019, 00:00

  • PMD18 A COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCE

    May 1, 2019, 00:00

  • PIT12 COST OF PARAQUAT POISONING IN COLOMBIA

    May 1, 2019, 00:00

  • PIH32 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS IN HUNGARY: A NATIONWIDE COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    May 1, 2019, 00:00

  • PIN84 THE ROLE OF COMORBIDITIES, INFECTIONS, AND TREATMENTS IN SEPSIS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PDB60 COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA

    May 1, 2019, 00:00

  • PMD6 THE ACIST I CVI® VARIABLE RATE CONTRAST DELIVERY SYSTEM REDUCES COSTS OF CORONARY CATHETERIZATIONS COMPARED WITH MANUAL INJECTION

    May 1, 2019, 00:00

  • PCV91 FACTORS ASSOCIATED WITH AVOIDING HEALTHCARE AMONG ADULTS WITH HYPERTENSION: AN ANALYSIS OF THE 2015 MEDICARE CURRENT BENEFICIARY SURVEY

    May 1, 2019, 00:00

  • PCN314 REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION

    May 1, 2019, 00:00

  • PMH30 UNDERSTANDING TRENDS IN DEMENTIA AND COGNITIVE IMPAIRMENT IN THE UNITED STATES: EVIDENCE FROM THE HEALTH AND RETIREMENT STUDY (HRS)

    May 1, 2019, 00:00

  • PDB90 FEASIBILITY OF A MULTI-COMPONENT DIABETES MANAGEMENT INTERVENTION BY PHARMACISTS: COORDINATION WITHIN A COMMUNITY PHARMACY NETWORK

    May 1, 2019, 00:00

  • PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA

    May 1, 2019, 00:00

  • PNS23 CONSIDERATIONS FOR UPDATING EXISTING LINGUISTICALLY VALIDATED CLINICAL OUTCOME ASSESSMENTS (COAS)

    May 1, 2019, 00:00

  • PND66 EVALUATION OF AN INTERPROFESSIONAL TELEHEALTH PROGRAM FOR PATIENTS WITH EPILEPSY

    May 1, 2019, 00:00

  • PDG73 TRENDS, PATIENT AND PRESCRIBER CHARACTERISTICS AND OFF-LABEL USE OF GABAPENTINOIDS AMONG UNITE STATES AMBULATORY CARE VISITS FROM 2003-2015

    May 1, 2019, 00:00

  • PIH22 TIME COSTS OF ADMINISTERING CHLAMYDIA SCREENING TO AFRICAN AMERICAN MEN IN NON-CLINICAL SETTINGS

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PMU73 HOSPITAL INPATIENT OUTCOME OF HEPATITIS C PATIENTS CO-INFECTED WITH HIV IN THE UNITED STATES: RESULTS FROM 2014 NATIONAL INPATIENT SAMPLE

    May 1, 2019, 00:00

  • PMD3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS COST-EFFECTIVE IN THE PRIMARY PREVENTION POPULATION IN MEXICO: AN ECONOMIC EVALUATION OF THE IMPROVE SCA STUDY

    May 1, 2019, 00:00

  • PCN308 REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON–SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2019, 00:00

  • PMH47 PREVALENCE AND FACTORS ASSOCIATED WITH ANTIPSYCHOTIC POLYPHARMACY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS64 HEALTH-RELATED QUALITY OF LIFE INEQUALITIES BY GENDER IDENTITY AND SEXUAL ORIENTATION AND ROLE OF DEPRESSION AS AN EXPLANATORY VARIABLE

    May 1, 2019, 00:00

  • Multiple Diseases - Health Technology Assessment

    May 1, 2019, 00:00

  • PND48 ADHERENCE TO MIGRAINE PROPHYLACTICS IS ASSOCIATED WITH IMPROVED HEALTH RESOURCE UTILIZATION

    May 1, 2019, 00:00

  • PMH46 WHAT IS THE EFFECTIVENESS OF INCLUDING PHARMACISTS IN COLLABORATIVE CARE PROGRAMS FOR MENTAL HEALTH TREATMENT? A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS220 CHARACTERISTICS AND METHODS OF INCORPORATING RANDOMIZED AND NON-RANDOMIZED EVIDENCE IN NETWORK META-ANALYSES: A SCOPING REVIEW

    May 1, 2019, 00:00

  • Editorial Board

    Apr 9, 2019, 09:28

  • Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare

    Apr 1, 2019, 00:00

  • Adoption of New Medical Technologies: The Case of Customized Individually Made Knee Implants

    Apr 1, 2019, 00:00

  • Conditional Financing of Drugs in the Netherlands: Past, Present, and Future—Results From Stakeholder Interviews

    Apr 1, 2019, 00:00

  • Eliciting Health State Utilities Using Paired-Gamble Methods: The Role of the Starting Point

    Apr 1, 2019, 00:00

  • Patient-Centered Item Selection for a New Preference-Based Generic Health Status Instrument: CS-Base

    Apr 1, 2019, 00:00

  • Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis

    Apr 1, 2019, 00:00

  • Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine [Editor's Choice]

    Apr 1, 2019, 00:00

  • Measuring Survival Benefit in Health Technology Assessment in the Presence of Nonproportional Hazards

    Apr 1, 2019, 00:00

  • Copyright/Subscription

    Apr 1, 2019, 00:00

  • Estimating Joint Health Condition Utility Values [Editor's Choice]

    Apr 1, 2019, 00:00

  • Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

    Apr 1, 2019, 00:00

  • Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies [Editor's Choice]

    Apr 1, 2019, 00:00

  • Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model

    Apr 1, 2019, 00:00

  • To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland

    Apr 1, 2019, 00:00

  • A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis [Editor's Choice]

    Apr 1, 2019, 00:00

  • Table of Contents

    Apr 1, 2019, 00:00

  • Correction

    Apr 1, 2019, 00:00

  • Editorial Board

    Mar 18, 2019, 18:11

  • Editorial Board

    Mar 13, 2019, 10:06

  • Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine

    Mar 1, 2019, 00:00

  • Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

    Mar 1, 2019, 00:00

  • Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data [Editor's Choice]

    Mar 1, 2019, 00:00

  • Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

    Mar 1, 2019, 00:00

  • Comparative Effectiveness of Computed Tomography Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma [Editor's Choice]

    Mar 1, 2019, 00:00

  • Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups [Editor's Choice]

    Mar 1, 2019, 00:00

  • Copyright/Subscription

    Mar 1, 2019, 00:00

  • Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018

    Mar 1, 2019, 00:00

  • Valuation of Health States Considered to Be Worse Than Death—An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies

    Mar 1, 2019, 00:00

  • Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE

    Mar 1, 2019, 00:00

  • Evaluating Canadians’ Values for Drug Coverage Decision Making

    Mar 1, 2019, 00:00

  • Table of Contents

    Mar 1, 2019, 00:00

  • Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions

    Mar 1, 2019, 00:00

  • Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports

    Mar 1, 2019, 00:00

  • Correction

    Mar 1, 2019, 00:00

  • Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials

    Mar 1, 2019, 00:00

  • Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data

    Mar 1, 2019, 00:00

  • Editorial Board

    Feb 1, 2019, 10:11

  • Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

    Feb 1, 2019, 00:00

  • The Cost-Effectiveness of Financial Incentives for Viral Suppression- HPTN 065 Study

    Feb 1, 2019, 00:00

  • The Internal Validity of Discrete Choice Experiment Data- A Testing Tool for Quantitative Assessments [Editor's Choice]

    Feb 1, 2019, 00:00

  • Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis

    Feb 1, 2019, 00:00

  • Table of Contents

    Feb 1, 2019, 00:00

  • Copyright/Subscription

    Feb 1, 2019, 00:00

  • Estimating CHU-9D Utility Scores from the WAItE- A Mapping Algorithm for Economic Evaluation

    Feb 1, 2019, 00:00

  • Economic Evaluation of Stem Cell Therapies in Neurological Diseases- A Systematic Review

    Feb 1, 2019, 00:00

  • Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women

    Feb 1, 2019, 00:00

  • Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

    Feb 1, 2019, 00:00

  • Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs [Editor's Choice]

    Feb 1, 2019, 00:00

  • A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)

    Feb 1, 2019, 00:00

  • Methods for Measuring Multiple Medication Adherence- A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group

    Feb 1, 2019, 00:00

  • Equity Weights for Socioeconomic Position- Two Methods—Survey of Stated Preferences and Epidemiological Data

    Feb 1, 2019, 00:00

  • Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines

    Feb 1, 2019, 00:00

  • Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke

    Feb 1, 2019, 00:00

  • The Retraction of a Trial Included in a Meta-Analysis of Interventions to Enhance Oral Medication Adherence

    Feb 1, 2019, 00:00

  • Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic ...

    Feb 1, 2019, 00:00

  • Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology [Editor's Choice]

    Feb 1, 2019, 00:00

  • Market Consolidation and Mortality in Patients Initiating Hemodialysis

    Jan 1, 2019, 00:00

  • Table of Contents

    Jan 1, 2019, 00:00

  • Instructions for Authors

    Jan 1, 2019, 00:00

  • Pediatric Quality of Life Instruments in Oral Health Research: A Systematic Review

    Jan 1, 2019, 00:00

  • Identifying Patients With Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Healthcare Data

    Jan 1, 2019, 00:00

  • Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice

    Jan 1, 2019, 00:00

  • EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set

    Jan 1, 2019, 00:00

  • The EQ-5D and the EuroQol Group

    Jan 1, 2019, 00:00

  • Correspondence

    Jan 1, 2019, 00:00

  • Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?

    Jan 1, 2019, 00:00

  • Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?

    Jan 1, 2019, 00:00

  • Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports

    Jan 1, 2019, 00:00

  • Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group

    Jan 1, 2019, 00:00

  • Copyright/Subscription

    Jan 1, 2019, 00:00

  • Assessing Emotional Functioning with Increased Power: Relative Validity of a Customized EORTC Short Form in the International ACTION Trial

    Jan 1, 2019, 00:00

  • Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA [Editor's Choice]

    Jan 1, 2019, 00:00

  • Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter? [Editor's Choice]

    Jan 1, 2019, 00:00

  • Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life

    Jan 1, 2019, 00:00

  • Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol [Editor's Choice]

    Jan 1, 2019, 00:00

  • Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator

    Jan 1, 2019, 00:00

  • Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping

    Dec 1, 2018, 00:00

  • Realizing the “Great Potential” of MCDA in HTA

    Dec 1, 2018, 00:00

  • Impact of Non-Adherence and Flare Resolution on the Cost-Effectiveness of Treatments for Gout- Application of a Linked Pharmacometric/Pharmacoeconomic Model

    Dec 1, 2018, 00:00

  • Cost-Utility Analysis of Apixaban versus Warfarin in Atrial Fibrillation Patients with Chronic Kidney Disease

    Dec 1, 2018, 00:00

  • Cost-Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina- Trial-Based Analysis of the Hypertension Control Program in Argentina

    Dec 1, 2018, 00:00

  • Prediction of Drug-Related Risks Using Clinical Context Information in Longitudinal Claims Data

    Dec 1, 2018, 00:00

  • Table of Contents

    Dec 1, 2018, 00:00

  • Performance of a Bayesian Approach for Imputing Missing Data on the SF-12 Health-Related Quality-of-Life Measure

    Dec 1, 2018, 00:00

  • A Rights-Based Approach for Service Providers to Measure the Quality of Life of Children with a Disability

    Dec 1, 2018, 00:00

  • Copyright/Subscription

    Dec 1, 2018, 00:00

  • Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma

    Dec 1, 2018, 00:00

  • Time Is Money- Investigating the Value of Leisure Time and Unpaid Work

    Dec 1, 2018, 00:00

  • Does Inclusion of Interactions Result in Higher Precision of Estimated Health State Values?

    Dec 1, 2018, 00:00

  • A Method for Approximating Future Entry of Generic Drugs

    Dec 1, 2018, 00:00

  • Editorial Board

    Nov 29, 2018, 18:06

  • Copyright/Subscription

    Nov 26, 2018, 17:43

  • Table of Contents

    Nov 1, 2018, 00:00

  • Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States- The Impact of Wording and Perspective

    Nov 1, 2018, 00:00

  • Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non–Small Cell Lung Cancer

    Nov 1, 2018, 00:00

  • Calculating the Expected Value of Sample Information Using Efficient Nested Monte Carlo- A Tutorial

    Nov 1, 2018, 00:00

  • A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes

    Nov 1, 2018, 00:00

  • Predictors of Drug Shortages and Association with Generic Drug Prices- A Retrospective Cohort Study

    Nov 1, 2018, 00:00

  • Editorial Board

    Nov 1, 2018, 00:00

  • General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale

    Nov 1, 2018, 00:00

  • Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous Population

    Nov 1, 2018, 00:00

  • Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure- Multiple Sclerosis Impact Scale–Eight Dimensions–Patient Version (MSIS-8D-P)

    Nov 1, 2018, 00:00

  • Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire

    Nov 1, 2018, 00:00

  • Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey

    Nov 1, 2018, 00:00

  • Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease

    Nov 1, 2018, 00:00

  • Editorial Board

    Oct 11, 2018, 13:00

  • PCV6 - SACUBITRIL/VALSARTAN IN HEART FAILURE- PROJECTED HEALTH OUTCOMES IN PORTUGAL

    Oct 1, 2018, 00:00

  • PIN120 - VARIATIONS IN RABIES VACCINE ADMINISTRATION AMONG RABIES EXPOSURE AND BITE VISITS IN UNITED STATES EMERGENCY DEPARTMENT SETTINGS

    Oct 1, 2018, 00:00

  • PIN30 - AN ECONOMIC MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF TRIVALENT INFLUENZA VACCINE HIGH DOSE FOR THE ELDERLY POPULATION IN ENGLAND AND WALES

    Oct 1, 2018, 00:00

  • PHP153 - KEY STAKEHOLDERS PERCEPTIONS OF HEOR USAGE IN LEBANON

    Oct 1, 2018, 00:00

  • PCP68 - MEDICAL ACCESS STRATEGY TO IMPROVE ACCESS TO INNOVATIVE AND EXPENSIVE THERAPY IN FRANCE

    Oct 1, 2018, 00:00

  • PMS39 - THRESHOLD PRICES FOR IMPROVEMENTS IN KNEE AND HIP REPLACEMENT- EVIDENCE FROM ROUTINELY COLLECTED DATA

    Oct 1, 2018, 00:00

  • PMH27 - RETROSPECTIVE HEALTHCARE CLAIMS DATA ANALYSIS FOR CHILDREN/ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER RECEIVING SECOND-LINE PHARMACOTHERAPY IN GERMANY, EVALUATING PATIENT CHARACTERISTICS AND HEALTHCARE COSTS

    Oct 1, 2018, 00:00

  • PCV130 - VALUE OF IMPLEMENTATION OF PHARMACEUTICAL CARE FOR CARDIOVASCULAR DISEASES IN LMICS- A HYPOTHETICAL SIMULATION FOR DECISION MAKING

    Oct 1, 2018, 00:00

  • PRM189 - SUBJECTIVE MEASURE MAY BE MORE SENSITIVE IN IDENTIFYING PROGNOSTIC FACTORS OF FUNCTIONAL OUTCOME AMONG OLDER ADULTS WITH SURGICALLY-TREATED HIP FRACTURE – FINDINGS FROM A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PRM259 - THE CHALLENGES OF ESTIMATING MULTI-STATE MODEL TRANSITIONS IN RARE DISEASES- INFORMING AN ECONOMIC DECISION MODEL FOR DUCHENNE MUSCULAR DYSTROPHY

    Oct 1, 2018, 00:00

  • PMU71 - ESTIMATING THE CLINICAL AND ECONOMIC BURDEN OF ADDITIONAL HOSPITALISATION ASSOCIATED WITH HYPERKALAEMIA AND RAASI THERAPY MANAGEMENT- A MODELLING STUDY IN PATIENTS WITH CHRONIC KIDNEY DISEASE OR HEART FAILURE

    Oct 1, 2018, 00:00

  • PRM38 - HOW MUCH IS YOUR LIFE WORTH? DEFINING WHAT THE WILLINGNESS TO PAY FOR A QALY IS AND SHOULD BE

    Oct 1, 2018, 00:00

  • PSY131 - ACCESS TO ORPHAN DRUGS (OD) IN SPAIN- ANALYSIS OF NUSINERSEN’S CASE

    Oct 1, 2018, 00:00

  • Unique Review Criteria and Patient and Stakeholder Reviewers- Analysis of PCORI’s Approach to Research Funding

    Oct 1, 2018, 00:00

  • PHP196 - DEVELOPMENT STRATEGIES PROMOTING PHARMACEUTICAL INDUSTRY TO IMPROVE HEALTHCARE MANAGEMENT

    Oct 1, 2018, 00:00

  • PDB102 - THERAPY ADJUSTMENT FOLLOWING DPP-4 INHIBITOR INITIATION IN T2DM PATIENTS WITH CREATININE CLEARANCE 50 ML/MIN- A RETROSPECTIVE COHORT STUDY USING DATA FROM UK GENERAL PRACTICE

    Oct 1, 2018, 00:00

  • PCN359 - COMPARISON OF INSTITUTIONAL AND HOME HOSPICE CARE

    Oct 1, 2018, 00:00

  • PHP134 - THE CHALLENGES OF PHARMACEUTICAL INDUSTRY IN IRAN; THEIR ROOTS, RANKS, AND RESOLUTIONS

    Oct 1, 2018, 00:00

  • PCN218 - PERSONALIZED THERAPY DEVELOPMENT IN NSCLC DEMONSTRATES INTERSECTION BETWEEN INNOVATION AND POSITIVE COVERAGE DECISIONS

    Oct 1, 2018, 00:00

  • PND66 - COST EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH MULTIPLE SCLEROSIS IN CYPRUS

    Oct 1, 2018, 00:00

  • PCV29 - REAL-WORLD DOAC AND VKA USE- THE PHARMO-ANTICOAGULATION COHORT

    Oct 1, 2018, 00:00

  • PCN262 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH LUNG CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PRM75 - DEVELOPMENT OF MACHINE LEARNING BASED ABSTRACT DOCUMENT CLASSIFICATION FOR SUPPORTING SYSTEMATIC REVIEWS

    Oct 1, 2018, 00:00

  • PIN96 - HIV/AIDS PROBLEM IN UKRAINE- CHALLENGE AND ACHIEVEMENT

    Oct 1, 2018, 00:00

  • PHP364 - HOW TO USE RWE TO OPTIMIZE PR OF NEW HEALTH TECHNOLOGIES

    Oct 1, 2018, 00:00

  • PSY108 - COST-UTILITY ANALYSIS OF TOCILIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE TREATMENT OF GIANT CELL ARTERITIS IN ITALIAN PATIENTS

    Oct 1, 2018, 00:00

  • PCN5 - TREATMENTS OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER IN ROUTINE CLINICAL PRACTICE – A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PND16 - PHARMACEUTICAL TREATMENT OF MILD ALZHEIMER’S DISEASE IN GERMANY – RESULTS FROM A DELPHI PANEL

    Oct 1, 2018, 00:00

  • PHP68 - HOW REGULATORY PATHS FOR E-HEALTH SOLUTIONS COULD FURTHER IMPACT MARKET ACCESS IN THE UNITED STATES AND THE EUROPEAN UNION

    Oct 1, 2018, 00:00

  • PHP252 - IS FACTOR ANALYSIS AS CREDIBLE AS OTHER TESTS OF DIFFERENCE AND ASSOCIATION FOR EVALUATING THE VALIDITY OF QUALITY OF LIFE MEASURES? ASSESSING THE CONVERGENT AND DISCRIMINANT VALIDITY OF THE WOMEN’S HEALTH QUESTIONNAIRE AGAINST THE ...

    Oct 1, 2018, 00:00

  • PCN338 - THE EVOLUTION OF TREATMENT ALGORITHMS IN NON-SMALL-CELL LUNG CANCER- IMPLICATIONS FOR REIMBURSEMENTS IN ENGLAND

    Oct 1, 2018, 00:00

  • PMD52 - YIELD AND COSTS OF POINT-OF-CARE SCREENING TEST VERSUS CASE FINDING TO DIAGNOSE CELIAC DISEASE IN PEDIATRIC PATIENTS

    Oct 1, 2018, 00:00

  • PRM230 - A SIMPLE NEW METHOD FOR COMBINING BINOMIAL COUNTS OR PROPORTIONS WITH HAZARD RATIOS FOR EVIDENCE SYNTHESIS OF TIME-TO-EVENT DATA

    Oct 1, 2018, 00:00

  • PHP282 - NEW AIFA INNOVATION ALGORITHM- IS IT REALLY A STEP FORWARD IN ALIGNING AIFA’S DECISION WITH EUROPEAN HTAS?

    Oct 1, 2018, 00:00

  • PHP201 - DEVELOPMENT OF MEDICATION SAFETY STANDARDS IN SELECTED HOSPITALS IN IRAN

    Oct 1, 2018, 00:00

  • PRM96 - COST-EFFECTIVENESS OF PRECISION ONCOLOGY DECISIONS- CHALLENGES IN METHODOLOGY

    Oct 1, 2018, 00:00

  • PHP193 - THE USE OF MEDTECH INNOVATION BRIEFINGS (MIBS) TO ENCOURAGE IMPLEMENTATION OF INNOVATIVE TECHNOLOGIES- A REVIEW OF PUBLISHED BRIEFINGS FROM 2014-2018

    Oct 1, 2018, 00:00

  • PRM121 - COMPARATIVE IMPACT OF TWO VARICELLA VACCINES ON VARICELLA EPIDEMIC DYNAMICS IN ITALY

    Oct 1, 2018, 00:00

  • PCV134 - REAL-WORLD DATA SOURCES FOR HEART FAILURE RESEARCH- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PCN303 - ASSESSING THE VALUE OF NOVEL IMMUNO-ONCOLOGY (I-O) THERAPIES- HOW CONSISTENT IS THE HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES' CONSIDERATION OF THE SURVIVAL BENEFIT IN THE ABSENCE OF LONG-TERM DATA?

    Oct 1, 2018, 00:00

  • PSY210 - HEALTH-RELATED QUALITY OF LIFE AFTER BARIATRIC SURGERY – A PROSPECTIVE COHORT STUDY

    Oct 1, 2018, 00:00

  • PRS28 - COST OF ILLNESS DUE TO BACTERIAL PNEUMONIA IN THE ADULT POPULATION IN DOMINICAN REPUBLIC FROM A PUBLIC PERSPECTIVE DURING 2018

    Oct 1, 2018, 00:00

  • PSS28 - ECONOMIC EVALUATION OF LONG TERM CARE SERVICES- LESSONS LEARNED FROM A COST-EFFECTIVENESS ANALYSIS OF VISION REHABILITATION SERVICES IN ENGLAND

    Oct 1, 2018, 00:00

  • PRS64 - RIGHT TO BREATHE, RIGHT TO CHOOSE?

    Oct 1, 2018, 00:00

  • PGI5 - CLINICAL AND DEMOGRAPHIC RISK FACTORS AND COSTS OF SURGICAL SITE INFECTION AFTER COLORECTAL SURGERY

    Oct 1, 2018, 00:00

  • PHP144 - IMPACT OF A CREATIVE QUALITY IMPROVEMENT STRATEGY TO REDUCE PATIENT WAIT TIMES BETWEEN PRIMARY AND SPECIALITY CARE IN A TERTIARY, UNIVERSITY PUBLIC HOSPITAL IN PORTUGAL

    Oct 1, 2018, 00:00

  • PRM239 - DOES MATCHING ADJUSTED INDIRECT COMPARISON (MAIC) WORK? RESULTS FROM A SIMULATION STUDY

    Oct 1, 2018, 00:00

  • PIN17 - BUDGET IMPACT ANALYSIS OF LIPOSOMAL AMPHOTERICIN B VERSUS AMPHOTERICIN B LIPID COMPLEX FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS IN A TERTIARY HOSPITAL IN THE KINGDOM OF SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PCV45 - BUDGET IMPACT ANALYSIS OF ACEI AND ARBS II DRUGS IN PATIENTS WITH ARTERIAL HYPERTENSION

    Oct 1, 2018, 00:00

  • PRM152 - A GENERIC BAYESIAN DES MODEL FOR MULTI-STATE DISEASE PROGRESSION

    Oct 1, 2018, 00:00

  • PMU18 - UK EPIDEMIOLOGY AND CLINICAL BURDEN OF VACCINE-PREVENTABLE CHILDHOOD INFECTIOUS DISEASES- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSS14 - BUDGET IMPACT ANALYSIS OF CONBERCEPT AND RANIBIZUMAB IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION IN CHINA

    Oct 1, 2018, 00:00

  • PIN84 - THE STUDY OF THE CONSUMPTION OF ANTIVIRAL DRUGS USED FOR PHARMACOTHERAPY IN PATIENTS WITH ACUTE RESPIRATORY VIRAL INFECTIONS IN UKRAINE

    Oct 1, 2018, 00:00

  • PDB103 - FINANCIAL ACCESS TO HEALTH CARE USE IN DIABETICS WITH HIGH-DEDUCTIBLE HEALTH PLAN (HDHP)

    Oct 1, 2018, 00:00

  • PCN25 - ROLE OF PROGRESSION FREE SURVIVAL IN THE APPROVAL PROCESS AND EUROPEAN HTA ASSESSMENTS

    Oct 1, 2018, 00:00

  • PCN382 - QUALITY OF LIFE IN LONG-TERM CANCER SURVIVORS- IMPLICATIONS FOR FUTURE HEALTH TECHNOLOGY ASSESSMENTS IN ONCOLOGY

    Oct 1, 2018, 00:00

  • PRM242 - USING NON-RANDOMISED EVIDENCE OR CLINICAL ASSUMPTIONS TO MAKE CONNECTIONS IN NETWORK META-ANALYSIS - A CASE STUDY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PDB64 - SHORT-TERM COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC IN JAPANESE PATIENTS WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PCN203 - HEALTHCARE RESOURCE USE IN PATIENTS WITH END-STAGE ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL)- RESULTS OF SEVEN SEMI-STRUCTURED INTERVIEWS ACROSS LEADING UK CENTRES

    Oct 1, 2018, 00:00

  • PCN85 - SAVING HEALTHCARE AND SOCIETAL COSTS BY CHANGING THE ROUTE OF ADMINISTRATION OF ONCOLOGY DRUGS

    Oct 1, 2018, 00:00

  • PSS9 - DRUGS UTILISATION IN THE ITALIAN SETTING- THE CASE OF WAMD, DME AND RVO

    Oct 1, 2018, 00:00

  • PHP110 - SUBSTANTIAL HEALTH GAINS FROM HEATH-SYSTEM-WIDE PATIENT BLOOD MANAGEMENT IMPLEMENTATION- ANALYTICS FOR EUROPE

    Oct 1, 2018, 00:00

  • PRM205 - A CRITIQUE OF YOUTUBE AS A DATA SOURCE FOR THE QUALITATIVE EXPLORATION OF PATIENT REPORTED INFORMATION ON ACUTE MYELOID LEUKEMIA.

    Oct 1, 2018, 00:00

  • PIN39 - IS THE UNIVERSAL POPULATION HEPATITIS C VIRUS SCREENING A COST-EFFECTIVE STRATEGY? A SYSTEMATIC REVIEW OF THE ECONOMIC EVIDENCE

    Oct 1, 2018, 00:00

  • PCP19 - AN UPDATED NICE POSITION ON THE EQ-5D-5L VALUATION SET

    Oct 1, 2018, 00:00

  • PDB77 - LONG-TERM COST-EFFECTIVENESS ANALYSIS OF IDEGLIRA VERSUS IGLARLIXI FOR THE TREATMENT OF PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN IN THE ITALIAN SETTING

    Oct 1, 2018, 00:00

  • PRM149 - OPEN-SOURCE DISCRETE EVENT SIMULATION MODEL FOR MAJOR DEPRESSION DISORDER (MDD)- AN UPDATE SUITABLE FOR NEW GENERATION TREATMENT?

    Oct 1, 2018, 00:00

  • PND96 - FOUR-YEAR RESOURCE USE AND COSTS ASSOCIATED WITH ADMINISTRATION AND MONITORING OF DISEASE MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS

    Oct 1, 2018, 00:00

  • PRM68 - IMPUTATION METHODS FOR MISSING DATA IN COST-UTILITY ANALYSES ALONGSIDE RANDOMIZED CONTROLLED TRIALS- AGGREGATE OR NON-AGGREGATE?

    Oct 1, 2018, 00:00

  • PCN48 - REAL-WORLD TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER- RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY

    Oct 1, 2018, 00:00

  • PCN361 - HEALTH ECONOMIC VALUE PROPOSITIONS FOR SUBCUTANEOUS TRASTUZUMAB AND THEIR TRANSFERABILITY TO CENTRAL-EASTERN EUROPEAN COUNTRIES

    Oct 1, 2018, 00:00

  • PDB126 - FACTORS INFLUENCING FOOD CHOICES OF PEOPLE WITH TYPE 2 DIABETES- A Q METHODOLOGY STUDY

    Oct 1, 2018, 00:00

  • PMU40 - LIVE BIRTH RATE (LBR), ONGOING PREGNANCY RATE (OPR) AND OVARIAN HYPERSTIMULATION SYNDROME (OHSS) RISK WITH ORIGINATOR VERSUS BIOSIMILAR RECOMBINANT FOLLITROPIN ALFA- A POOLED ANALYSIS OF CLINICAL TRIAL DATA

    Oct 1, 2018, 00:00

  • PRM233 - THE USE OF THE TWO-STAGE METHOD IN ADJUSTING FOR TREATMENT CROSSOVER. A SIMULATION STUDY.

    Oct 1, 2018, 00:00

  • PCN234 - IMPACT OF BALDUZZI LAW (CNN CLASS) ON TIME TO MARKET AND ON PRICES FOR ONCOLOGY DRUGS IN ITALY

    Oct 1, 2018, 00:00

  • PIN59 - ESTIMATING THE COST-EFFECTIVENESS OF ISAVUCONAZOLE FOR THE TREATMENT OF PATIENTS WITH POSSIBLE INVASIVE ASPERGILLOSIS IN THE UNITED KINGDOM

    Oct 1, 2018, 00:00

  • PHP245 - UNDERSTANDING THE IMPACT OF REAL WORLD EVIDENCE ON REIMBURSEMENT DECISIONS ACROSS EU5 COUNTRIES USING A WEB-BASED PORTAL TO ENGAGE PAYERS

    Oct 1, 2018, 00:00

  • PSS51 - ANALYSIS OF TOPICAL PREPARATIONS FOR TREATMENT OF ONYCHOMYCOSIS IN UKRAINE

    Oct 1, 2018, 00:00

  • PIN83 - PHARMACOECONOMIC EVALUATION OF PUBLIC PROCUREMENT CRITERIA IN THE NATIONAL PNEUMOCOCCAL VACCINE IMMUNIZATION PROGRAM- SLOVENIA AS A CASE STUDY

    Oct 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53 (current)
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »